Y-Intercept (HK)’s MiMedx Group MDXG Stock Holding History

Y-Intercept (HK)’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-16,371	Closed	-$64.7K	–	1986
2026 Q1	$64.7K	Buy	+16,371	New	+$82.5K	﹤0.01%	1471

Other funds holding MDXG

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Y-Intercept (HK)'s MDXG Position: Q2 2026 in Review

Y-Intercept (HK) sold out of MiMedx Group (MDXG) in Q2 2026, closing a stake of 16,371 shares — an estimated $64.7K sold.

Y-Intercept (HK) first reported a position in MDXG in Q1 2026 and held it in 1 quarter. The position peaked at $64.7K in Q1 2026. 227 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

Y-Intercept (HK) reported no remaining MiMedx Group position as of Q2 2026 after selling out during the quarter.
Y-Intercept (HK) sold 16,371 MiMedx Group shares in Q2 2026, an estimated $64.7K.
Y-Intercept (HK) first reported a position in MiMedx Group in Q1 2026 and held it in 1 quarter.
Y-Intercept (HK)'s MiMedx Group position peaked at $64.7K in Q1 2026.
227 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.